CIK: 0002092021
Total reported value
$315.1M
Reporting period: 2026-03-31 · Number of holdings: 114
Seven Fleet Capital Management LP disclosed 114 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $315.1M and a quarterly turnover rate of 147.1%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "S"
Seven Fleet Capital Management LP's disclosed holdings carry a Herfindahl concentration index of 0.105 — mathematically equivalent to about 10 equally-sized positions, well below its 114 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes vary widely across the portfolio (a coefficient of variation of 3.33), with a handful of outsized bets alongside many smaller positions.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 7% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Trim CGON
-95.0% -$57.8M
Trim COGT
-30.2% -$1.9M
Trim SLNOEUR
-11.0% -$2.1M
Add TNGX
+133.3% $8.6M
Add AGIO
+560.2% $6.2M
Add PCVX
+327.6% $5.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Cg Oncology INC | Stock-Other | 30.92% | +30.92% | NEW | |
| 2 | TNGX | Tango Therapeutics INC | Stock-Other | 3.33% | +2.04% | +133.31% | |
| 3 | RVMD | Revolution Medicines INC | Stock-Healthcare | 2.49% | -1.06% | +22.78% | |
| 4 | TYRA | Tyra Biosciences INC | Stock-Other | 2.38% | +0.96% | +145.96% | |
| 5 | LQDA | Liquidia CORP | Stock-Other | 2.25% | +0.12% | +105.85% | |
| 6 | AGIO | Agios Pharmaceuticals INC | Stock-Other | 2.25% | +1.67% | +560.24% | |
| 7 | IPSC | Century Therapeutics INC | Stock-Other | 2.11% | +2.11% | NEW | |
| 8 | ELVN | Enliven Therapeutics INC | Stock-Other | 2.04% | +1.00% | +64.11% | |
| 9 | PCVX | Vaxcyte INC | Stock-Other | 2.00% | +1.21% | +327.56% | |
| 10 | ✓ | Tango Therapeutics INC | Stock-Other | 2.00% | +2.00% | NEW | |
| 11 | COGT | Cogent Biosciences INC | Stock-Other | 1.82% | -3.33% | -30.22% | |
| 12 | ✓ | Avalo Therapeutics INC | Stock-Other | 1.71% | +1.71% | NEW | |
| 13 | ✓ | Minerva Neurosciences INC | Stock-Other | 1.70% | +1.70% | NEW | |
| 14 | CGON | Cg Oncology INC | Stock-Other | 1.63% | -40.94% | -95.00% | |
| 15 | PHVS | Pharvaris N.V. | Stock-Other | 1.55% | +0.51% | +212.12% | |
| 16 | ABVX | Abivax Sa-adr | Stock-Other | 1.52% | +0.29% | +218.93% | |
| 17 | DNTH | Dianthus Therapeutics INC | Stock-Other | 1.45% | +1.04% | +270.34% | |
| 18 | ✓ | Pharvaris N V | Stock-Other | 1.29% | +1.29% | NEW | |
| 19 | CYTK | Cytokinetics INC | Stock-Healthcare | 1.28% | +0.84% | +492.83% | |
| 20 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 1.23% | -2.85% | -11.00% | |
| 21 | ✓ | Enliven Therapeutics INC | Stock-Other | 1.19% | +1.18% | NEW | |
| 22 | ERAS | Erasca INC | Stock-Other | 1.14% | +1.14% | NEW | |
| 23 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 1.13% | +1.13% | NEW | |
| 24 | ✓ | Cytomx Therapeutics INC. | Stock-Other | 1.07% | +1.06% | NEW | |
| 25 | AVTX | Avalo Therapeutics INC | Stock-Other | 1.01% | +0.23% | +237.56% | |
| 26 | EPRX | Eupraxia Pharmaceuticals INC | Stock-Other | 1.00% | +1.00% | NEW | |
| 27 | IDYA | Ideaya Biosciences INC | Stock-Other | 0.91% | +0.91% | NEW | |
| 28 | TSHA | Taysha Gene Therapies INC | Stock-Other | 0.89% | +0.27% | +274.18% | |
| 29 | ASND | Ascendis Pharma A/S | Stock-Other | 0.88% | +0.06% | +114.80% | |
| 30 | CMPX | Compass Therapeutics INC | Stock-Other | 0.87% | — | -9.10% | |
| 31 | DMRA | Damora Therapeutics INC | Stock-Other | 0.83% | +0.83% | NEW | |
| 32 | 4XC1 | Kalvista Pharmaceuticals INC | Stock-Other | 0.82% | +0.29% | +165.40% | |
| 33 | RLAY | Relay Therapeutics INC | Stock-Other | 0.81% | +0.39% | +253.07% | |
| 34 | AXSM | Axsome Therapeutics INC | Stock-Healthcare | 0.75% | — | +8.49% | |
| 35 | ✓ | Compass Therapeutics INC | Stock-Other | 0.71% | +0.71% | NEW | |
| 36 | ✓ | Dianthus Therapeutics INC | Stock-Other | 0.71% | +0.71% | NEW | |
| 37 | ✓ | Eupraxia Pharmaceuticals INC | Stock-Other | 0.63% | +0.63% | NEW | |
| 38 | DFTX | Definium Therapeutics INC | Stock-Other | 0.60% | +0.60% | NEW | |
| 39 | MLYS | Mineralys Therapeutics INC | Stock-Other | 0.60% | — | +65.55% | |
| 40 | ✓ | Soleno Therapeutics INC | Stock-Other | 0.57% | +0.57% | NEW | |
| 41 | MDGL | Madrigal Pharmaceuticals INC | Stock-Healthcare | 0.56% | — | +82.42% | |
| 42 | CTMX | Cytomx Therapeutics INC | Stock-Other | 0.55% | +0.41% | +659.54% | |
| 43 | LONA | Leonabio INC | Stock-Other | 0.54% | — | +28.70% | |
| 44 | SVRA | Savara INC | Stock-Other | 0.51% | +0.25% | +371.13% | |
| 45 | CATX | Perspective Therapeutics INC | Stock-Other | 0.50% | +0.50% | NEW | |
| 46 | ASMB | Assembly Biosciences INC | Stock-Other | 0.49% | — | -23.88% | |
| 47 | ✓ | Sab Biotherapeutics INC | Stock-Other | 0.49% | +0.49% | NEW | |
| 48 | NERV | Minerva Neurosciences INC | Stock-Other | 0.48% | +0.48% | NEW | |
| 49 | ZLAB | Zai Lab Ltd-adr | Stock-Other | 0.46% | +0.46% | NEW | |
| 50 | TARS | Tarsus Pharmaceuticals INC | Stock-Other | 0.44% | — | +340.00% |
Performance for Q3 2026
-1.3%
Performance Last 4 Quarters
+8.8%
Based on 3 months of available history
Based on 43% of reported portfolio value with available pricing
Seven Fleet Capital Management LP's most significant position changes for 2026-03-31: New buy: Cg Oncology INC; New buy: Century Therapeutics INC (IPSC); New buy: Tango Therapeutics INC; New buy: Avalo Therapeutics INC; New buy: Minerva Neurosciences INC.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | TNGX | Tango Therapeutics INC | +2% | +133.31% | Add |
| 2 | AGIO | Agios Pharmaceuticals INC | +1.7% | +560.24% | Add |
| 3 | PCVX | Vaxcyte INC | +1.2% | +327.56% | Add |
| 4 | DNTH | Dianthus Therapeutics INC | +1% | +270.34% | Add |
| 5 | ELVN | Enliven Therapeutics INC | +1% | +64.11% | Add |
| 6 | TYRA | Tyra Biosciences INC | +1% | +145.96% | Add |
| 7 | CYTK | Cytokinetics INC | +0.8% | +492.83% | Add |
| 8 | PHVS | Pharvaris N.V. | +0.5% | +212.12% | Add |
| 9 | CTMX | Cytomx Therapeutics INC | +0.4% | +659.54% | Add |
| 10 | RLAY | Relay Therapeutics INC | +0.4% | +253.07% | Add |
| 11 | ABVX | Abivax Sa-adr | +0.3% | +218.93% | Add |
| 12 | 4XC1 | Kalvista Pharmaceuticals INC | +0.3% | +165.40% | Add |
| 13 | TSHA | Taysha Gene Therapies INC | +0.3% | +274.18% | Add |
| 14 | SVRA | Savara INC | +0.3% | +371.13% | Add |
| 15 | AVTX | Avalo Therapeutics INC | +0.2% | +237.56% | Add |
| 16 | LQDA | Liquidia CORP | +0.1% | +105.85% | Add |
| 17 | ASND | Ascendis Pharma A/S | +0.1% | +114.80% | Add |
| 18 | RVMD | Revolution Medicines INC | -1.1% | +22.78% | Add |
| 19 | SLNOEUR | Soleno Therapeutics INC | -2.9% | -11.00% | Trim |
| 20 | COGT | Cogent Biosciences INC | -3.3% | -30.22% | Trim |
| 21 | CGON | Cg Oncology INC | -40.9% | -95.00% | Trim |
| 22 | ✓ | Cg Oncology INC | — | NEW | New buy |
| 23 | IPSC | Century Therapeutics INC | — | NEW | New buy |
| 24 | ✓ | Tango Therapeutics INC | — | NEW | New buy |
| 25 | ✓ | Avalo Therapeutics INC | — | NEW | New buy |
| 26 | ✓ | Minerva Neurosciences INC | — | NEW | New buy |
| 27 | 430 | Terns Pharmaceuticals INC | — | EXIT | Sold out |
| 28 | ✓ | Pharvaris N V | — | NEW | New buy |
| 29 | ✓ | Enliven Therapeutics INC | — | NEW | New buy |
| 30 | ERAS | Erasca INC | — | NEW | New buy |
| 31 | ROIV | Roivant Sciences Ltd. | — | NEW | New buy |
| 32 | ✓ | Cytomx Therapeutics INC. | — | NEW | New buy |
| 33 | EPRX | Eupraxia Pharmaceuticals INC | — | NEW | New buy |
| 34 | EXEL | Exelixis INC | — | EXIT | Sold out |
| 35 | IDYA | Ideaya Biosciences INC | — | NEW | New buy |
| 36 | DMRA | Damora Therapeutics INC | — | NEW | New buy |
| 37 | ✓ | Compass Therapeutics INC | — | NEW | New buy |
| 38 | ✓ | Dianthus Therapeutics INC | — | NEW | New buy |
| 39 | ✓ | Eupraxia Pharmaceuticals INC | — | NEW | New buy |
| 40 | DFTX | Definium Therapeutics INC | — | NEW | New buy |
| 41 | ✓ | Soleno Therapeutics INC | — | NEW | New buy |
| 42 | CATX | Perspective Therapeutics INC | — | NEW | New buy |
| 43 | ✓ | Sab Biotherapeutics INC | — | NEW | New buy |
| 44 | NERV | Minerva Neurosciences INC | — | NEW | New buy |
| 45 | BLTE | Belite Bio INC - Adr | — | EXIT | Sold out |
| 46 | ZLAB | Zai Lab Ltd-adr | — | NEW | New buy |
| 47 | DYN | Dyne Therapeutics INC | — | EXIT | Sold out |
| 48 | CRVS | Corvus Pharmaceuticals INC | — | NEW | New buy |
| 49 | AM6 | Amicus Therapeutics INC | — | EXIT | Sold out |
| 50 | ✓ | Vaxcyte INC | — | NEW | New buy |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-15 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-04-02 | Amendment | View on EDGAR |
| 2025-12-31 | 2026-02-26 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0002038170
Total reported value
$315.1M
56 stks
2025-12-31
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0001904664
Total reported value
$315.1M
48 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0002033920
Total reported value
$315.1M
69 stks
2026-03-31
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0001595430
Total reported value
$1.4B
17 stks
2026-03-31
3 of the top 5 holdings overlap, including Revolution Medicines INC
CIK 0001678378
Total reported value
$468.9M
6 stks
2026-03-31
2 of the top 5 holdings overlap, including Revolution Medicines INC
CIK 0001727492
Total reported value
$1.5B
28 stks
2026-03-31
2 of the top 5 holdings overlap, including Liquidia CORP